Works matching IS 09255710 AND DT 2014 AND VI 100 AND IP 4


Results: 18
    1
    2
    3
    4
    5
    6
    7

    Factors associated with effects of Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era.

    Published in:
    International Journal of Hematology, 2014, v. 100, n. 4, p. 386, doi. 10.1007/s12185-014-1636-5
    By:
    • Uike, Naokuni;
    • Choi, Ilseung;
    • Tsuda, Mariko;
    • Haji, Shojirou;
    • Toyoda, Kousuke;
    • Suehiro, Youko;
    • Abe, Yasunobu;
    • Hayashi, Toshinobu;
    • Sawamoto, Hirofumi;
    • Kaneko, Koichiro;
    • Shimokawa, Mototsugu;
    • Nakagawa, Makoto
    Publication type:
    Article
    8
    9
    10
    11
    12

    Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival.

    Published in:
    International Journal of Hematology, 2014, v. 100, n. 4, p. 370, doi. 10.1007/s12185-014-1646-3
    By:
    • Ichikawa, Kunimoto;
    • Noguchi, Masaaki;
    • Koike, Michiaki;
    • Aritaka, Nanae;
    • Sekiguchi, Yasunobu;
    • Sunami, Yoshitaka;
    • Tsutsui, Miyuki;
    • Hosone, Masaru;
    • Hirano, Takao;
    • Gotoh, Akihiko;
    • Komatsu, Norio
    Publication type:
    Article
    13
    14
    15
    16
    17